Daily happenings?., page-312

So we can expect news Monday at the opening. Here’s hoping we have some FOMO tomorrow pushing us into double figures.

1. Phase 1 Pharmacodynamic and Pharmacokinetic Study of the Geranylgeranyltransferase I Inhibitor PTX-100 (GGTI-2418) in Patients with Advanced Malignancies
   Result Type: Paper
   Number: 1705
   Presenter: H. Miles Prince
   Program: Oral and Poster Abstracts
   Session: 624. Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Poster I
   Time and Location:
   Saturday, December 9, 2023: 5:30 PM-7:30 PM
   Halls G-H (San Diego Convention Center)
   Search Result:
   
   ... K. Yannakou, MBBS (Hons), FRACP, FRCPA, PhD2*, Vinod Ganju, MBBS, FRACP3*, Steven Grant, M.D.4*, Said Sebti5* and H. Miles Prince, MD61Prescient Therapeutics, Limited, Allyn, WA2Epworth HealthCare, Melbourne, VIC, Australia3Peninsula Oncology Centre Consulting Suite, Frankston, VIC, AUS4Massey Cancer Center, Virginia Commonwealth University, ...